Literature DB >> 24485952

Transfusion related anaphylaxis during orthotopic liver transplantation.

Allison Paroskie1, Garrett S Booth2.   

Abstract

Acute non-hemolytic transfusion reactions, consisting of both allergic and febrile reactions, are common occurring in up to 10.2% of transfused blood products, however anaphylaxis, or severe allergic reactions, are rare following transfusion. The incidence of anaphylaxis is more common after the transfusion of plasma containing products with estimations from 1:10,000-33,000 units of platelets and 1:29,000-50,000 units of fresh frozen plasma (FFP) compared with 1:50,000-200,000 units of red blood cells. Despite the rare occurrence, the clinical significance of transfusion related anaphylaxis can be severe with 12 reported fatalities over a 5-year span. We report a case of FFP related anaphylaxis in a patient anticipating orthotopic liver transplant (OLT) with a unique peri-operative treatment plan.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24485952      PMCID: PMC4106124          DOI: 10.1016/j.transci.2014.01.012

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  3 in total

1.  Serious hazards of transfusion: a decade of hemovigilance in the UK.

Authors:  Dorothy Stainsby; Hilary Jones; Deborah Asher; Claire Atterbury; Aysha Boncinelli; Lisa Brant; Catherine E Chapman; Katy Davison; Rebecca Gerrard; Alexandra Gray; Susan Knowles; Elizabeth M Love; Clare Milkins; D Brian L McClelland; Derek R Norfolk; Kate Soldan; Clare Taylor; John Revill; Lorna M Williamson; Hannah Cohen
Journal:  Transfus Med Rev       Date:  2006-10

Review 2.  Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults.

Authors:  M Warmuth; P Mad; C Wild
Journal:  Acta Anaesthesiol Scand       Date:  2011-12-12       Impact factor: 2.105

3.  Allergic transfusion reactions: an evaluation of 273 consecutive reactions.

Authors:  Ronald E Domen; Gerald A Hoeltge
Journal:  Arch Pathol Lab Med       Date:  2003-03       Impact factor: 5.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.